Clinical Significance of a Circulating Tumor Cell-based Classifier in Stage IB Lung Adenocarcinoma: A Multicenter, Cohort Study

To investigate the effectiveness of a CTC-based classifier in stratifying stage IB LUAD. SUMMARY OF BACKGROUND DATA: Stage IB LUADs have an approximately 70% 5-year survival rate. The clinical application of ACT is controversial due to inconsistent results in a series of trials and few useful guide...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Lijuan, Zhong, Xiaoming, Liu, Wei, Xu, Di, Lei, Yiyan, Zhou, Jianwen, Jiang, Wenting, He, Qiong, Sun, Yu, Ke, Zunfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831033/
https://www.ncbi.nlm.nih.gov/pubmed/33630430
http://dx.doi.org/10.1097/SLA.0000000000004780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831033/
https://www.ncbi.nlm.nih.gov/pubmed/33630430
http://dx.doi.org/10.1097/SLA.0000000000004780

Ejemplares similares